# reload+after+2024-01-23 09:36:01.306333
address1§3 Forbury Place
address2§23 Forbury Road
city§Reading
zip§RG1 3JH
country§United Kingdom
phone§44 11 8952 8100
website§https://www.convatecgroup.com
industry§Medical Instruments & Supplies
industryKey§medical-instruments-supplies
industryDisp§Medical Instruments & Supplies
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
fullTimeEmployees§10000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Karim  Bitar', 'age': 58, 'title': 'CEO & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 2447000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jonathan Peter Mason', 'age': 59, 'title': 'Group CFO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1061200, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John  Haller', 'title': 'Executive VP and Chief Quality & Operations Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Divakar  Ramakrishnan Ph.D.', 'title': 'Executive VP, Chief Technology Officer and Head of Research & Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kate  Postans', 'title': 'Vice President of Investor Relations & Corporate Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Evelyn  Douglas J.D.', 'title': 'Executive VP, Chief of Corporate Strategy & Business Development and General Counsel', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Natalia  Kozmina', 'title': 'Executive VP, Chief Human Resources Officer & ESG Stewardship', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kjersti  Grimsrud Biotechnology, M.Sc.', 'age': 62, 'title': 'President & COO of Infusion Care', 'yearBorn': 1961, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Supratim  Bose', 'age': 71, 'title': 'President & COO of Global Emerging Markets', 'yearBorn': 1952, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Shepherd', 'title': 'President & COO of Global Advanced Wound Care', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§3
boardRisk§3
compensationRisk§1
shareHolderRightsRisk§1
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§0.05
dividendYield§0.020599999
exDividendDate§1692230400
payoutRatio§1.8153999
fiveYearAvgDividendYield§2.28
beta§0.53
priceToSalesTrailing12Months§2.4083924
currency§GBp
forwardEps§0.12
pegRatio§1.4
lastDividendValue§1.38
lastDividendDate§1692230400
exchange§LSE
quoteType§EQUITY
shortName§CONVATEC GROUP PLC ORD 10P
longName§ConvaTec Group PLC
firstTradeDateEpochUtc§1477465200
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§fb7df1c4-4bfa-3134-8564-6f1f205506a6
messageBoardId§finmb_39347275
targetHighPrice§3.09
targetLowPrice§2.19
targetMeanPrice§2.74
targetMedianPrice§2.79
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§19
quickRatio§0.894
earningsGrowth§0.128
grossMargins§0.55191004
ebitdaMargins§0.2132
trailingPegRatio§2.206
